Why the study?
Does under-utilisation of evidence-based treatment explain the unfavourable prognosis in diabetic patients with acute myocardial infarction?
Does under-utilisation of evidence-based treatment explain the unfavourable prognosis in diabetic patients with acute myocardial infarction?
The study highlights that poor outcomes in diabetic patients with acute myocardial infarction are partly driven by the under-utilization of evidence-based therapies.
No takes yet. Share an insight, caveat, or question.
Prioritize evidence-based therapies in diabetic AMI patients to narrow outcome gaps; confirms under-utilization as a modifiable contributor to excess risk.
Anna Norhammar (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: